Aspira Women’s Health CFO Replaced, CEO Takes Interim Role
Company Announcements

Aspira Women’s Health CFO Replaced, CEO Takes Interim Role

Aspira Women’s Health (AWH) has shared an announcement.

Aspira Women’s Health Inc. has terminated Dr. Torsten Hombeck as CFO due to a personal civil matter that does not relate to the company’s operations or finances. CEO Nicole Sandford has stepped in as interim CFO while the company searches for a permanent replacement. Sandford’s extensive executive background, including over three decades of experience in strategy, operations, and risk management, ideally positions her to manage the company’s financial responsibilities during this transition.

Find detailed analytics on AWH stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAspira Women’s Health Engages Investors with Performance Insights
TheFlyAspira Women’s Health announces publication of data on blood test
GlobeNewswireAspira Women’s Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App